The Plant Journal
© John Wiley & Sons Ltd
Edited By: Christoph Benning
Impact Factor: 5.468
ISI Journal Citation Reports © Ranking: 2015: 13/209 (Plant Sciences)
Online ISSN: 1365-313X
1. About The Plant Journal
1.1 Aims and scope
The Plant Journal (TPJ) publishes four categories of papers:
Original Research Articles
The aim of TPJ is to publish exciting, high quality science that addresses fundamental questions in plant biology. Typically, the research will provide insight into an as yet unknown mechanism or poorly understood process, will constitute a highly significant contribution to our understanding of plants, and be of general interest to the plant science community. All areas of plant biology are welcome and the experimental approaches used can be wide-ranging and interdisciplinary. Many fully-sequenced genomes and related technologies are now available. TPJ welcomes functional genomics manuscripts when a scientific question, rather than the technology used, has driven the research.
Technical Advance articles
Technical Advance articles must be useful to a large proportion of the community and not be narrow in scope. Demonstration of how the Technical Advance has led to new insights into a biological mechanism must also be made. Manuscripts that describe significant advances in the use of an already existing technology will be considered, but variations on existing methods, or improvements on vectors, would not qualify for consideration.
Resource articles will typically be data-rich and provide an important, novel reference source for the field. Such an article could encompass a careful comparative analysis of ecotypes or strains of a model or reference organism, but also large-scale reference datasets derived from transcriptomics, proteomics, or metabolomics that the community will likely continue to use for metadata analysis leading to novel biological insights. First time genome sequences of plant or algal species or specific ecotypes or strains of a reference organism, and the respective comparative genomic analysis, will be welcome under this category. Metabolic flux maps and their computational basis, or newly reconstructed metabolic networks for reference organisms or specific tissues, will also be considered. Resource articles covering large-scale datasets must have a concise conclusion highlighting examples of novel biological insights and/or how these data might lead to such insights in the future through continued metadata analysis.
Special Issue articles
TPJ aims to publish special issues on a regular basis, typically comprising specially commissioned review papers on an emerging topic identified by the Editorial Board. Unsolicited review articles will not be considered.
1.2 What TPJ does not publish
TPJ does not publish manuscripts that extend previously published work to another species; nor those that provide no fundamental advance in basic plant biology. Manuscripts that mostly include descriptive work, lacking mechanistic insights, or large-scale datasets without highlighting the current or future biological significance, will be declined. Manuscripts primarily covering biotechnologically-relevant advances are not considered.
If authors have any questions as to whether their manuscript falls within the scope of TPJ, they should email a summary highlighting the significance of their study to the Editorial Office (email@example.com) for advice prior to full submission.
2. Submission of Manuscripts
Papers are evaluated for publication in TPJ on the understanding that no part has been, or will be, published elsewhere. No handling or page charges apply to manuscripts submitted to TPJ; however, authors do pay for the reproduction of colour figures/photographs, unless he or she is a member of the Society of Experimental Biology (see section 3.11. below).
2.1. Where to submit
TPJ’s online submission site can be found at http://mc.manuscriptcentral.com/tpj. Only manuscripts submitted via the journal's online site will be considered for publication. If assistance is needed during online submission, please email firstname.lastname@example.org. For guidelines on the submission of revised manuscripts, see section 5, below.
2.2. Files to be submitted
- Text as Microsoft Word (any version), Rich Text Format or Post Script.
- Figures as (preferably) TIFF, EPS or PDF, but see below for further options/advice.
- Supporting Information files (optional) as required. Please note that the maximum file size for each Supporting Information file is 20 MB.
- Related manuscripts that are in press or submitted elsewhere.
2.3. Suggesting potential editors and reviewers
At submission, authors must select two potential Handling Editors and provide names of up to six potential reviewers for their manuscript. Choosing a Handling Editor closest to the field of interest will speed up the review process, as reassignment to a more appropriate Handling Editor may be necessary otherwise. Handling Editors who work at the same institution as any of the authors should not be selected. Suggested Handling Editors and reviewers should not have been advisors, advisees, co-authors or collaborators within the past three years.
Authors also have the option of suggesting up to two potential reviewers whom they would prefer not be selected. If this option is chosen, the reason(s) must be stated in the cover letter, or your request will not be considered. If the reason involves a conflict of interest, this should be explained. Please note: The Handling Editor will consider but not guarantee to honour such requests.
If you have any problems during submission, please contact email@example.com for assistance.
2.4. Editorial evaluation of manuscripts
All submissions will be considered by the Editorial Board to determine whether they fall within the scope of the journal and to ensure homogeneity in terms of scientific standards. Submissions that do will be sent out for full external review; those that do not will be returned to the submitting author quickly so that submission elsewhere will not be delayed. Manuscripts sent out for external review will typically be assessed by at least two experts; however, in extenuating circumstances (e.g. because of a delay caused by an overdue reviewer), the Handling Editor may make a decision based on the comments of only one reviewer, plus his/her own assessment of the manuscript.
Resubmissions of previously rejected manuscripts will typically be sent to the same reviewers who saw the original version, providing those reviewers are available. However, in some cases, the Handling Editor may decide that it is not appropriate to re-invite one or more of the original reviewers and/or may judge that a fresh reviewer is needed. There is no time deadline for resubmissions. However, authors should bear in mind that the impact of their work, and hence its suitability for TPJ, may be lessened as knowledge advances.
Under this scheme, manuscripts previously considered by a high-impact, general science journal including, but not limited to, Nature, Science, or Proceedings of the National Academy of Sciences (PNAS), can be submitted to TPJ without reformatting. The aim is to allow swift consideration of the work, and only those manuscripts that have to be resubmitted following review or directly go on to be provisionally accepted for publication will need to be reformatted to TPJ style. Authors wishing to submit under this initiative must state their intention in their cover letter, making sure mention is made of the journal where the manuscript was previously considered. Please note, previous reviewer comments and/or decision letters will not be considered as part of the submission. If uploaded, they will be deleted by the Editorial Office prior to review. The review process itself will proceed in exactly the same way as standard submissions to TPJ, except that reviewers will be informed that the manuscript has been submitted via the TSI, and instructed accordingly regarding the different formatting.
2.6. Status enquiries
The status of submitted papers can be followed by logging into your Author Centre at http://mc.manuscriptcentral.com/tpj. All questions about the status of manuscripts under review should be directed to the Editorial Office, and not to the Editor. Please use the email address firstname.lastname@example.org. Correspondence relating to all other editorial matters should be directed to email@example.com.
Only manuscripts in English will be considered. Spelling should conform to that in The Concise Oxford Dictionary or Websters New Collegiate Dictionary. All unusual symbols should be identified. Care should be taken to differentiate between certain letters and numbers (e.g. the letter O and zero; the letter I and the number 1). Authors for whom English is a second language may choose to have their manuscript professionally edited before submission. A list of independent suppliers of editing services can be found at http://authorservices.wiley.com/bauthor/english_language.asp. All services are to be arranged and paid for by the author, and use of one of these services does not guarantee acceptance.
3.2. Word limit
The Plant Journal recommends that Original Articles and Technical Advances are no longer than 7000 words with no more than 7 Figures and Tables in total. It is recommended that Resource Articles are no more than 15000 words, with a total of no more than 15 Figures and Tables. Longer papers will be considered provided that they are concise and the additional length is needed to properly convey the results of the work. However, as space in the journal is at a premium, the Editors reserve the right to require authors to reduce the length of their manuscripts. The following sections must be included as part of the word count: summary; introduction; results; discussion; experimental procedures; acknowledgements; table titles; and figure legends. The following sections are excluded from the word count: title page, including author list and author affiliations; running head; any words that form part of a table or figure; references; and supporting information.
All sections of the manuscript should be double-spaced, with all margins at least 30 mm. All pages must be numbered consecutively from the title page, including the pages with the acknowledgements, references, tables, and figure legends.
3.4. Title page
The title page should include the full title of the paper; the full names of all the authors; the name(s) and address(es) of the institution(s) at which the work was carried out (the present addresses of the authors, if different from the above, should appear in a footnote); the name, address, telephone and fax numbers and email address of the author to whom all correspondence and proofs should be sent; the email addresses of all the authors if possible; a suggested running title of not more than 50 characters, including spaces; up to 10 key words, listed in order of importance, which must include the species names; accession numbers for sequence data. The total word count must be given on the front page of the manuscript. A breakdown of the word count for each section of the manuscript should also be provided, including the references.
Submission of a manuscript to TPJ implies that all persons listed as authors qualify for authorship, and all those who qualify are listed. Each author should have participated sufficiently in the work to take public responsibility for the content, and each author must have approved the final version of the submitted manuscript.
3.5. Significance Statement
Authors should provide a Significance Statement with their submission. The Significance Statement will be available for reviewers as part of the peer review process and will ultimately appear within the online Table of Contents. The Significance Statement should consist of up to two sentences of no more than 75 words in total and should not repeat the title, as it appears directly below the title. The goal of the statement is to explain the significance and relevance of the findings of the manuscript to a broad readership, from undergraduate students to research scientists. Suggested content for Significance Statements includes: an introductory sentence and/or why a problem/unanswered question was important to address; what has been shown/what does the manuscript do to fill a gap in our knowledge; what it means to the field as a whole. References should not be included.
NOTE: Significance Statements may undergo editorial revision.
Generally, all papers should be divided into the following sections in the order: (1) Summary, not exceeding 250 words; (2) Significance statement of up to two sentences of no more than 75 words total; (3) Introduction; (4) Results; (5) Discussion; (6) Experimental procedures; (7) Accession numbers; (8) Acknowledgements; (9) Short legends for Supporting Information; (10) References; (11) Tables; (12) Figure legends; (13) Figures. The Results and Discussion sections may be combined and may contain subheadings. Figures and Supporting Information should be supplied as separate files, and not incorporated into the main manuscript text file. Authors should also refer to the Editorial Policies section below before preparing their manuscript.
3.7. Units and abbreviations
Système International (SI) units should be used, as given in Units, Symbols and Abbreviations, published by the Royal Society of Medicine Services Ltd, 1 Wimpole Street, London W1M 8AE, UK. Acceptable abbreviations that do not need to be defined are listed here: http://www.blackwellpublishing.com/pdf/em1.pdf. Other abbreviations should be written out in full the first time they are used.
3.8. Scientific names, protein and gene names, and trade names
Complete scientific names should be given when organisms are first mentioned. The genus name may subsequently be abbreviated to the initial. It is important to differentiate between genes and proteins: All gene names and loci should be written in italic type; proteins should be upright. Trade names should be capitalized, and the manufacturer’s name and website given.
3.9. ‘Unpublished’ or ‘not shown’ data
The statements ‘data not shown’ or ‘unpublished’ should be avoided; instead, the data should be included in the Supporting Information.
3.10. Personal communications
Personal communications should not appear in the reference list, but may be referred to in the text. It is the authors' responsibility to obtain permission from colleagues to include their work as a personal communication. Such letters of permission should be included as Supporting Information when the manuscript is submitted.
All statements concerning quantitative differences between experimental conditions should be based on quantitative data and adequate statistical treatment. Where relevant, blots should be scanned to obtain quantitative data. Statistics should be based on independent biological samples. The deviation parameter, the number of biological samples and the statistical procedures should be provided for each dataset either in the Experimental Procedures section or in the figure legends. Technical replicates should be averaged before statistical treatment and not used to calculate deviation parameters. In the case of multiple comparisons (e.g. microarray data), the probability of false positives should be considered in the analysis. Experimental procedures should be sufficiently detailed to enable the experiments to be reproduced.
With the exception of composite photographs suitable for full-page reproduction (maximum width, including lettering, 16.8 cm), all other figures will be typeset to a maximum width of 8 cm (including all lettering). Labelling on the figures should be in 8pt Helvetica if possible. Figure sections should be designated with lower case letters. Magnification bars should be given on electron and light microscope photographs. Error bars must be included on graphs, and the method used to derive the error bars included in the legend.
Figure legends should contain sufficient information to be understood without reference to the text, but should not contain excessive methodological detail. Each should begin with a short title for the figure. All symbols and abbreviations used in the figures should be explained. In the full text online edition of the journal, figure legends might be truncated in abbreviated links to the full screen version. Therefore, the first 100 characters of any legend should inform the reader of key aspects of the figure.
The journal welcomes colour photographs, and any figures that are reviewed in colour must be published in colour. It is the policy of TPJ for authors to pay the full cost for the reproduction of their colour artwork. If there is colour artwork in your manuscript when it is accepted, Wiley will require you to complete and return a Colour Work Agreement (CWA) form before the paper is published. This form can be downloaded online from TPJ__CWA_Form_2016.pdf. The charges are £150 for the first colour figure and £50 for each subsequent figure. Once completed, please post the form to:
Customer Services (OPI)
John Wiley & Sons Ltd
European Distribution Centre
New Era Estate
TPJ offers free colour to members of the Society for Experimental Biology. In order to claim free colour you must include a valid and current SEB membership number with your completed CWA form. Under exceptional circumstances, authors may request a waiver of the colour charges. This must be done, in writing, at the time of submission of the manuscript, and authors must justify to the Editorial Office that inclusion of the figure(s) in colour is essential for interpretation of the results.
Artwork should be supplied in electronic form. TIFF, EPS and PDF are the preferred formats for final file versions, but for the purposes of the review process, other formats such as JPG or PowerPoint are also acceptable. The main concern at this early stage is that the images in the PDF that is to be sent to the reviewers are of sufficient quality for the results they are displaying to be properly assessed. Also, to make the reviewer's job easier, the figure legend should be included directly underneath the figure, as well as in a separate list in the manuscript. If you are uploading TIFF, EPS or JPG files, this can be done directly in the online submission system. However, if uploading PDF or PowerPoint files, for example, you will need to include the legend underneath the figure yourself, before uploading. All colour artwork should be supplied in CMYK format. Further information on digital illustration standards is available at: http://authorservices.wiley.com/bauthor/illustration.asp.
3.13. Acknowledgement of funding
All sources of funding for the work reported, for all authors, must be acknowledged. Both the research funder and the grant number should be given for each source of funds. These details should appear in the Acknowledgements section.
Supporting Information, such as datasets or additional figures or tables, can be submitted. Supporting Information will not appear in print, but will be viewable via the online edition. Only material that is a valuable addition to the article should be included. Supporting Information will be reviewed. In exceptional circumstances, if the size or format of the Supporting Information is such that it cannot be accommodated on the journal's website, the authors may agree to make the Supporting Information available free of charge on a permanent external website, to which links will be set up from TPJ’s site. In such circumstances, the author takes full responsibility for advising Wiley if the URL of the website where the Supporting Information is located changes. The content of the Supporting Information must not be altered after the paper has been accepted for publication.
The availability of Supporting Information should be indicated in the main manuscript by a paragraph, to appear after the Acknowledgements, headed 'Supporting Information'. Short legends should be included here, listing the titles of all supporting figures, tables, data etc. Full (more detailed) legends for Supporting Information must also be uploaded as a separate Word document. This version will be used online, alongside where the Supporting Information is hosted, but not in the manuscript text, which instead uses the short versions of the legends. In order to protect reviewer anonymity, material posted on authors’ websites cannot be reviewed.
Supporting Information items should be referred to in the text as follows:
Supporting figures: Figure S1, Figure S2 etc.
Supporting tables: Table S1, Table S2 etc.
Supporting data: Data S1, Data S2 etc.
Supporting experimental procedures: Methods S1, Methods S2 etc.
Supporting animations: Movie S1, Movie S2 etc.
Any other text-based Supporting Information: Appendix S1, Appendix S2 etc.
The above order should be used when listing the Supporting Information legends, both in the short versions in the main manuscript text file, as well as in the separate full legends file.
3.15. Reporting of large-scale omics data
Reporting standards for large-scale omics datasets are constantly evolving and TPJ will follow common sense standards currently accepted in the field. Authors including microarray analysis should refer to the MIAME recommendations for guidance in preparing their manuscripts. Guidelines for the preparation of proteomics data can be found at http://www.psidev.info/miape/. For the current recommended practice on the preparation and reporting of metabolomics data, authors are referred to the publication by Fernie et al. (http://www.plantcell.org/content/23/7/2477.full).
We recommend the use of a tool such as EndNote or Reference Manager for reference management and formatting. EndNote reference styles can be searched for here: http://www.endnote.com/support/enstyles.asp Reference Manager reference styles can be searched for here: http://www.refman.com/support/rmstyles.asp.
References should be cited in the text by author and date, e.g. Shah and Klessig (1999). Joint authors should be referred to by et al. if there are more than two, e.g. Sambrook et al. (1989). More than one paper from the same author(s) in the same year must be identified by the letters a, b, c etc., placed after the year of publication. Listings of references in the text should be chronological, not alphabetical e.g. (Sambrook et al., 1989; Lacomme et al., 1999). At the end of the paper, references should be listed alphabetically according to the first named author. The full titles of papers, chapters and books should be given, and abbreviated names of journals, with the first and last page numbers. Examples:
Lacomme, C. and Santa Cruz, S. (1999) Bax-induced cell death in tobacco is similar to the hypersensitive response. Proc. Natl Acad. Sci. USA, 96, 7956-7961.
Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual 2nd edn. Cold Spring Harbor: Cold Spring Harbor Laboratory Press.
Shah, J. and Klessig, D.F. (1999) Salicylic acid: signal perception and transduction. In Biochemistry and Molecular Biology of Plant Hormones (Hooykaas, P.P.J., Hall, M.A. and Libbenga, K.R., eds). New York: Elsevier Science, pp. 513-541.
Tables should be typed on separate sheets. They should have a brief descriptive title and be self-explanatory. No vertical rules should be used. Units should appear in parentheses in the column headings, not in the body of the table. Repeated words or numerals on successive lines should be written in full. Please ensure that all tables are presented in an editable form, i.e. as text within a Word file rather than an embedded image or a pdf file.
4. Additional policies
4.1. Editorial policies
4.1.1. Priority statements / claims of novelty
Whilst TPJ prides itself in only publishing basic mechanistic insights into important biological problems that go beyond the current state of knowledge, making explicit priority statements or claims of novelty in the manuscript text should be avoided. The novelty of the work should be left to the reader to judge. In this context, authors should consider carefully their use of words such as ‘novel’, ‘new’ and ‘first’ throughout the manuscript. In particular, direct priority statements (e.g. “This is the first demonstration of…”) are not allowed.
4.1.2. Use of ‘regulate’ or ‘control’
It is the opinion of the Editorial Board that, in some cases, a title or sentence including the word ‘regulate’ (or similar; e.g. ‘regulator’, ‘regulates’ etc.), or ‘control’, can imply that one thing regulates or controls another, when it might not be true. For example, based on the inactivation of a gene and the resulting phenotype one might conclude that the encoded enzyme is essential for the metabolic process. However, this does not necessarily mean that the enzyme has a regulatory role in the process. In general, the terms ‘regulate’ or ‘control’ should be restricted to widely recognized, truly regulatory proteins, e.g. transcription factors. Principally, this policy concerns the 'headline' elements of a paper (i.e. title, running title, summary), but authors are asked to consider this instruction throughout the manuscript.
4.1.3. Use of 'crosstalk'
Although "crosstalk" is frequently used as shorthand for communication between two pathways (e.g. between two different hormone signalling pathways), it is the opinion of the Editorial Board that it can be applied too broadly, perhaps when the investigator is unsure as to exactly what kind of interaction occurs between different pathways. Authors are therefore asked to avoid ‘crosstalk’ and instead provide a more precise definition of what the interaction entails.
4.2. Conflict of Interest
Wiley requires that all authors disclose any potential conflict of interest. Any interest or relationship, financial or otherwise, which might be perceived as influencing an author’s objectivity is considered a potential conflict of interest. These must be disclosed when directly relevant or indirectly related to the work described in the manuscript. Potential conflicts of interest include, but are not limited to, patent or stock ownership, membership on a company’s board of directors, membership on an advisory board or committee for a company, or consultancy for or receipt of speaker’s fees from a company. The existence of a conflict of interest does not preclude publication in this journal. If the authors have no conflict of interest to declare, they must also state this at submission. It is the responsibility of the submitting author to review this policy with all authors and to collectively list in the cover letter to the Editor-in-Chief, in the manuscript (in the footnotes, Conflict of Interest or Acknowledgments section), and in the online submission system all pertinent commercial and other relationships.
4.3. Note to NIH Grantees
Pursuant to the NIH mandate, Wiley will post the accepted version of contributions authored by NIH grant holders to PubMed Central upon acceptance. This accepted version will be made publicly available 12 months after publication. For further information see http://www.wiley.com/go/nihmandate.
4.4. Data availability policy
Data that are integral to the paper must be made available in such a way as to enable readers to replicate, verify and build upon the conclusions published in the paper.
Data may be included as part of the main article where practical. We recommend that data for which public repositories are widely used and are accessible to all should be deposited in such a repository prior to publication (see below for Arabidopsis gene functional annotation data). The appropriate linking details and identifier(s) should then be included in the publication and where possible the repository, to facilitate linking between the journal article and the data. If such a repository does not exist, data should be included as supporting information to the published paper or authors should agree to make their data available upon reasonable request.
In general, the broad and systematic analysis of microarray datasets or RNA sequence datasets in papers published by TPJ must be accompanied by a complete dataset deposited in a publicly accessible repository. However, if the function of a specific gene or gene family is described that became first apparent in a microarray or RNA sequence experiment, and no further description of the analysis of the full dataset is provided in the manuscript, public deposition of the full dataset is not necessary for publication by TPJ.
4.5. Availability of biological and chemical material
Publication of a paper in TPJ explicitly requires that authors will provide, for non-profit research, all the biological and chemical materials not commercially available that are used for the experiments reported. To ensure complete transparency of this requirement, TPJ requires authors to state that these materials will be available on request. Requests must be reasonable with regard to the amount of material that can be provided and the sharing of costs, particularly when materials have required substantial effort for their production.
4.6. Arabidopsis gene functional annotation data
TPJ encourages authors whose manuscripts contain information on Arabidopsis genes to submit functional annotation data to The Arabidopsis Information Resource (TAIR) database. TPJ and TAIR are collaborating to collect one or more of the following types of information about the Arabidopsis gene/s described in papers submitted to TPJ:
- molecular function (for example: kinase activity, ATP synthase activity)
- biological process (for example: endosperm development, threonine biosynthesis)
- subcellular location (for example: nucleus, endoplasmic reticulum)
- expression pattern (for example: leaf, ovule, flower stage 10, seedling stage)
- protein-protein interaction (for example: AT1G01010 interacts with AT1G01020)
Authors are asked upon submission whether their manuscript contains one or more of the above types of information. If the answer is 'yes', and the manuscript is accepted for publication, authors will be reminded in the letter of acceptance to submit their data to TAIR, if they have not done so already. A link to TAIR's online submission tool is provided.
4.7. Registration of sequences
All papers containing nucleotide sequences must provide nucleotide sequence database accession numbers. Nucleotide data submitted to any of the collaborating databases of the International Nucleotide Sequence Database consortium, which includes EMBL, DDBJ and GenBank, will be shared amongst all. To obtain an EMBL accession number, please use the EMBL submission tool, Webin, at http://www.ebi.ac.uk/embl/Submission/webin.html. Full instructions are provided online. Accession numbers are normally provided within two days, or within five days for large amounts of data. Papers containing amino acid sequences must supply a UniProt/Swiss-Prot accession number. To obtain an accession number, please use the UniProt/Swiss-Prot data submission tool (SPIN) at http://www.ebi.ac.uk/swissprot/Submissions/submissions.html. Accession numbers for protein submissions through SPIN are normally returned within a week of submission. Nucleotide and amino acid sequence accession numbers should be incorporated into manuscripts after the References. Any paper that does not have accession number(s) by proof stage will not be published until they have been provided.
Authors should submit the revised version of their manuscript online via the submission site http://mc.manuscriptcentral.com/tpj following the instructions provided in their editorial correspondence. Any changes in authorship must be noted and explained in the cover letter.
After acceptance, the authors' files will be sent electronically to the Production Department. It is thus very important that the files uploaded at revision are in their final format and of sufficient quality for publication. At revision, authors should provide:
a) The manuscript text in Word format (all tracked changes removed). This file should be text only, should not contain figures and must not exceed 1MB in size. Tables must not be embedded, but provided in editable format.
b) Figures as high-resolution TIFF, EPS or PDF files; colour in CMYK format.
c) Supporting Information files as required. Please note that the maximum file size for each Supporting Information file is 20 MB.
d) Supporting Information legends: please include a short legend for each and every supporting file in the main manuscript text (to be placed in a paragraph before the references), and also provide a full legend for each file in a separate Word document. Even if the full legend is no different from the short legend, it should be included in this Word document. Please note: Supporting Information and their accompanying legends are NOT copyedited prior to publication. Therefore, please ensure that the quality of the English and writing in these files are of a high standard.
e) A copy of the text file with changes highlighted. Please ensure that you select 'Supporting Information for review only' as this file designation.
f) A letter of response to the reviewers' comments, detailing point-by-point the changes made and giving reasons for those not made.
g) A completed Colour Work Agreement form, if relevant (i.e. if your paper contains colour figures).
The usual TPJ word limit of 7000 words (see above for full information) does not apply to revised manuscripts. It can be exceeded, but only if the revisions required justify this. Revised manuscripts must be received within 2 months of authors being notified of provisional acceptance pending satisfactory revision. Revised manuscripts received after this time will be considered as completely new submissions and be subject again to the full review procedure. This time limit will be rigidly adhered to except under exceptional circumstances, which must be explained in full, in writing, to both the Handling Editor and the Managing Editor.
Revised manuscripts must be in their final form when submitted. The proofs received later are for correction of typographical errors only. They should not be used for final changes to articles; such changes must be made to the manuscript before it goes to Production.
6. License/Copyright agreement
After acceptance, the Corresponding Author will be asked to complete a license agreement for the publication of their paper. This will be an online process via Wiley's 'Author Services' system. Authors can choose the license agreement most appropriate for their paper, e.g. depending on funder requirements.
7. Production and publication
7.1. Production tracking
Online production tracking is now available for your article though Wiley’s Author Services. Author Services enables authors to track their article – once it has been accepted – through the production process to publication online and in print. Authors can choose to receive automated emails at key stages of production so they don’t need to contact the Production Editor to check on progress. Visit http://authorservices.wiley.com/bauthor/ for more details on online production tracking and for a wealth of resources including FAQs and tips on article preparation, submission and more.
7.2. Accepted Articles
TPJ publishes online the unedited final version of authors’ manuscripts on acceptance (see Accepted Articles). Authors should therefore take great care to ensure that the final versions of their manuscripts are as complete and error-free as possible. After copyediting, and proof correction, articles are published in Early View (see section 7.4. below).
Proofs will be downloaded as an Acrobat PDF file. Authors will be notified by email when their proofs are ready to download; Acrobat Reader will be required in order to read this file. This software can be downloaded (free of charge) from the following Web site: http://www.adobe.com/products/acrobat/readermain.html. This will enable the file to be opened, read on screen, and printed out in order for any corrections to be added. Further instructions will be sent with the proofs. In cases of absence, corresponding authors should arrange for a colleague to access their email to retrieve the proofs. Major alterations to the text will be charged to the author and may delay publication.
7.4. Early View
TPJ is covered by Wiley's Early View service. Early View articles are complete full-text articles published online in advance of their publication in a printed issue. Early View articles are complete and final. They have been fully reviewed, revised and edited for publication, and the authors' final corrections have been incorporated. Because they are in final form, no changes can be made after online publication. The nature of Early View articles means that they do not yet have volume, issue or page numbers, so Early View articles cannot be cited in the traditional way. They are therefore given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before it is allocated to an issue. After print publication, the DOI remains valid and can continue to be used to cite and access the article. More information about DOIs can be found at: http://www.doi.org/faq.html.
Free access to the final PDF offprint or your article will only be available via Author Services. Sign up for Author Services if you would like to access your PDF and enjoy the many other benefits the service offers. Additional offprints may be ordered from firstname.lastname@example.org.
OnlineOpen is available to authors of articles who wish to make their article immediately available to non-subscribers, or whose funding agency requires grantees to archive the final version of their article. With OnlineOpen, the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is made available to non-subscribers upon publication via Wiley Online Library, as well as deposited in the funding agency's preferred archive. The full list of terms and conditions can be found here. Any authors wishing to publish their paper via OnlineOpen will be required to complete the payment form available at: https://onlinelibrary.wiley.com/OnlineOpenOrder. There is no requirement to inform the Editorial Office prior to acceptance as to whether you intend to publish your paper via OnlineOpen. All OnlineOpen articles are treated in the same way as any other article, going through the journal's standard peer review process, and will be accepted or rejected based on their own merit.